Wistar researchers were recognized for their leadership and contributions to vaccinology recently at the International Society for Vaccines (ISV) annual Congress. The conference, held in October in…
Finding a cure has long been the holy grail of HIV research. Now new discoveries are putting that goal within reach, according to Wistar’s Luis Montaner, D.V.M., D.Phil.
As director of the institu…
Assistant professor Daniel Claiborne, Ph.D., pursues one of the hottest up-and-coming areas of research: CAR T cells, which are engineered immune cells designed to attack specific target Dr. Claibo…
Dr. Katalin Karikó, 2023 Nobel Laureate in Physiology or Medicine, received The Wistar Institute’s 2024 Helen Dean King Award and as a part of the day-long activities, Dr. Karikó spent time with Wi…
For Pancreatic Cancer Awareness Month, we sat down with Rahul S. Shinde, D.V.M., Ph.D., assistant professor in Wistar’s Ellen and Ronald Caplan Cancer Center who researches potential new therapies …
Infectious disease specialist & senior scientist in Wistar’s Lieberman lab, Dr. Soldan studies the connection between M.S. and Epstein Barr Virus. She is most intrigued with how the body respon…
Paul M. Lieberman, Ph.D., is leader of the Genome Regulation and Cell Signaling Program at the Ellen and Ronald Caplan Cancer Center. He studies how certain viruses, such as Epstein-Barr virus, est…
In July 2024, Jozef Madzo, Ph.D., joined Wistar’s faculty as an assistant professor and new director of the Bioinformatics Core Facility, which provides investigators with critical data analysis su…
In front of the 200-plus audience gathered in The Wistar Institute’s standing-room-only Sarah and Matthew Caplan Auditorium — as well as many more tuning in virtually — the 2023 Nobel Laureate in P…
The Wistar Institute celebrated the most successful fundraising campaign in its history with an evening reception at the Philadelphia Museum of Art. Donors, board members and Wistar staff gathered …
